Abstract
The luminal surface of blood vessels is covered with endothelium which possesses various antithrombogenic functions and maintain blood fluidity. The anti-thrombogenic functions include the production of PGI2, the secretion of tissue plasminogen activator, and the production of heparin-like proteoglycans and thrombomodulin(TM)(1). PGI2 inhibits platelet functions and causes blood vessel dilatation(2). Tissue plasminogen activator activates plasminogen to plasmin. Heparin-like proteoglycans activate antithrombin III from a progressive inhibitor to an immediate-type inhibitor, which inhibits activated factor Xa and thrombin(3). TM is an endothelial associated glycoprotein that convert thrombin from a procoagulant protease to an anticoagulante 4, 5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maruyama I. (1986) The regulation of blood coagulation by the endothelium. Acta Haematol Jpn. 49:146–153.
Baenziger N.L., Dillender M.J., and Majerus P.W. (1977) Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. Biochem. Biophys. Res. Commun. 78:294–301.
Marcum J.A., Fritze L., Galli S.J., Karp G.,and Rosenberg R.D. (1983) Microvascular heparin-like species with anticoagulant activity. Am. J. Physiol. 245: H725–H733.
Esmon C.T., and Owen W.G. (1981) Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc. Natl. Acad. Sei. USA 78: 2249–2252.
Maruyama I., Bell C.E., and Majerus P.W. (1985) Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J. Cell Biol.101:363–371.
Akashi M., Takeda S., Miyazaki T., Yashima E., Miyachi T., Maruyama I., Okadome T., Murata Y. (1989) Antithrombogenic poly(vinyl Chloride) with heparin- and/or prostaglandin I2-immobilized in hydrogels. J. Bioactive and Compatible Polym. 4:4–16.
Suzuki K., Kusumoto H., Deyashiki Y., Nishioka J., Maruyama I., Zushi M., Kawahara S., Honda G., Yamamoto S., and Horiguchi S. (1987) Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J. 6:1981–1987
Grode G.A., Pitman J., Crowley J. P., Leininger R.I. and Falb R.D. (1974) Surface-immobilized prostaglandins as a platelet protective agent. Trans. Am. Soc. Artif. Intern. Organs. 20:38–41
Ebert CD., Lee E.S., and Kim S. W. (1982) The antiplatelet activity of immobilized prostacyclin. J. Biomed. Mater. Res. 16:629–638
Jacobs H.A., Okano T., and Kim, S.W. (1989) Antithrombogenic surfaces Characterization and bioactivity of surface immobilized PGE1-heparin conjugate. J. Biomed. Mater. Res. 23:611–630
Chandy T., and Sharma, C.P. (1984) The antithrombogenic effect of prostaglandin E immobilized on albuminated polymer matrix. J Biomed. Mat. Res. 18:1115–1124.
O’Brien, J.R. (1962) Platelet aggregation I. Some effects of the adenosine phosphates, thrombin, and cocaine upon platelet adhesiveness. J. Clin. Pathol.15:446–452
Gomi K., Zushi M., Honda G., Kawahara S., Matsuzaki O., Kanabayashi T., Yamamoto S., Maruyama I., and Suzuki K. (1990) Antithrombogenic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood 75:1396–1399
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Japan
About this paper
Cite this paper
Maruyama, I., Akashi, M., Okadome, T. (1992). Antithrombogenic Biomaterials. Poly(Vinyl Chloride) with Heparin-and/or PGI2-Immobilized in Hydrogels and Thrombomodulin-Immobilized Beads.. In: Takada, A., Budzynski, A.Z. (eds) Hemostasis and Circulation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66925-8_29
Download citation
DOI: https://doi.org/10.1007/978-4-431-66925-8_29
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70096-8
Online ISBN: 978-4-431-66925-8
eBook Packages: Springer Book Archive